Your session is about to expire
← Back to Search
Behavioral Intervention
Virtual Reality Gaming for Pediatric Cancer
Phase 1
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, ~week 2 (post-transplant), ~week 4 (hospital discharge), intervention or wait period week 4, intervention or wait period week 8.
Awards & highlights
No Placebo-Only Group
Summary
This trial will investigate how a virtual reality game that combines mindfulness and exercise can help children with cancer during their recovery. The game will last for 8 weeks and can be used at home. Some participants
Who is the study for?
This trial is for children undergoing cancer rehabilitation. They must be able to participate in virtual reality gaming and mindfulness exercises over an 8-week program, starting either immediately or after a wait period.
What is being tested?
The study tests if virtual reality games that focus on exercise and mindfulness can benefit kids recovering from cancer. It compares two groups: one starts the program right away, the other waits for 8 weeks before beginning.
What are the potential side effects?
Since this involves virtual reality gaming, potential side effects may include dizziness, nausea, eye strain or headaches. However, these are typically mild and vary from person to person.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 0, ~week 2 (post-transplant), ~week 4 (hospital discharge), intervention or wait period week 4, intervention or wait period week 8.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, ~week 2 (post-transplant), ~week 4 (hospital discharge), intervention or wait period week 4, intervention or wait period week 8.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Physical activity
Secondary study objectives
Forced Expiratory Volume in the first second (FEV1)
Global Health
Minutes of gameplay
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate StartExperimental Treatment1 Intervention
Program starts in the hospital and lasts for 8 weeks after hospital discharge.
Group II: Waitlist ControlActive Control1 Intervention
After 8 weeks after hospital discharge, these participants start the 8 week intervention.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,357 Total Patients Enrolled